openPR Logo
Press release

Investor Alert: NBY, OP, STAI, PNPNF - Stocks Under $1 Complete Watch List Inside

08-21-2025 12:16 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Investor Alert: NBY, OP, STAI, PNPNF - Stocks Under $1 Complete

Microcap stocks under $1 are drawing trader and investor attention, spanning sectors from biotech and healthcare to shipping, AI security, wireless, and gold mining. Here are some of the most active names making headlines:

NovaBay Pharmaceuticals Inc. (NYSE: NBY) NovaBay is carving out a niche in the eyecare and skincare market with its flagship product, Avenova Registered Antimicrobial Lid and Lash Solution, clinically proven to remove microorganisms and debris from the skin around the eye. Widely used by eyecare professionals for blepharitis and dry-eye disease, Avenova is also available direct-to-consumer through online channels. With its targeted product line and growing adoption, NovaBay continues to advance in a competitive ophthalmic market.

OceanPal Inc. (NASDAQ: OP) Shipping operator OceanPal reported H1 2025 time charter revenues of $6.2M, down from $12.4M a year earlier. The company posted a net loss of $10.4M, with net loss attributable to common stockholders of $11.9M, compared to $10.3M in H1 2024. The revenue contraction underscores the challenges faced by smaller shipping firms in a volatile freight market, where demand softens while operating costs remain high.

ScanTech AI Systems Inc. (NASDAQ: STAI) ScanTech AI is enhancing its SENTINEL Trademark CT screening systems through a strategic service collaboration with Curie Technologies. The integration of Curie's SaaS platform will deliver real-time digital access to asset data, compliance info, and troubleshooting tools-a move aimed at boosting customer value across aviation, nuclear energy, and customs security markets. CEO Dolan Falconer emphasized the upgrade as a differentiator in highly regulated industries, while positioning ScanTech AI to grow its recurring revenue base.

Incannex Healthcare Inc. (NASDAQ: IXHL) Australia- and U.S.-listed Incannex announced positive Phase 2 patient-reported outcomes for its investigational therapy IHL-42X in obstructive sleep apnoea (OSA). Structured exit interviews revealed strong improvements in sleep quality, cognition, and daily functioning, aligning with FDA's patient-focused development framework. These findings strengthen Incannex's case for advancing IHL-42X toward later-stage clinical development in a condition affecting millions worldwide.

Peraso Inc. (NASDAQ: PRSO) Wireless innovator Peraso is navigating a complex strategic alternatives review after receiving an unsolicited non-binding proposal from Mobix Labs earlier this summer. While the Board and advisors opened the process to interested parties under confidentiality terms, Mobix declined, instead signaling potential direct engagement with shareholders. With no formal deal on the table, questions remain as to whether the proposal was a serious overture-or simply market noise-as Peraso continues evaluating options to maximize shareholder value.

Bonus: Canadian Gold Companies Trading in the U.S. - Juniors to Giants

Gold investors are on alert following President Trump's "No Tariffs on Gold" declaration. Three Canadian miners dual-listed in the U.S. are now in sharp focus: Power Metallic Inc. (OTCQB: PNPNF | TSX.V: PNPN), Element79 Gold Corp. (CSE: ELEM | OTCQB: ELMGF), and ESGold Corp. (CSE: ESAU | OTCQB: ESAUF)-all positioned for immediate investor interest. See Original News Article. [https://www.benzinga.com/pressreleases/25/08/ab47216819/gold-alert-juniors-to-giants-pnpn-v-elem-c-esau-c-riding-trumps-no-tariffs-on-gold-declaration-mo]

For investors tracking stocks under $1, these names highlight the breadth of opportunities across biopharma, AI, shipping, healthcare innovation, wireless tech, and gold mining. Each presents high-risk, high-reward dynamics in today's volatile microcap market-making them ones to watch closely in the weeks ahead.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=investor-alert-nby-op-stai-pnpnf-stocks-under-1-complete-watch-list-inside]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investor Alert: NBY, OP, STAI, PNPNF - Stocks Under $1 Complete Watch List Inside here

News-ID: 4152900 • Views:

More Releases from ABNewswire

Pulmonary Arterial Hypertension Market Expected to Gain Momentum Through 2034, According to DelveInsight | Merck, Janssen Pharma, Aerovate Therapeutics, Novartis, Insmed Inc, Chugai Pharma, Keros
Pulmonary Arterial Hypertension Market Expected to Gain Momentum Through 2034, A …
The Key Pulmonary Arterial Hypertension Companies in the market include - Aerovate Therapeutics, Novartis, Keros Therapeutics, Vigonvita Life Sciences, Insmed Incorporated, Chugai Pharmaceutical, Merck Sharp & Dohme, Janssen Pharmaceutical, Actelion, Gossamer Bio, Lung Biotechnology PBC, United Therapeutics, Gilead Science, Acceleron Pharma, Eiger BioPharmaceuticals, AstraZeneca, and others. DelveInsight's "Pulmonary Arterial Hypertension Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Pulmonary Arterial Hypertension, historical and forecasted epidemiology as
Best Language Learning App: Migaku Earns Industry Recognition
Best Language Learning App: Migaku Earns Industry Recognition
Migaku officially recognized as the best language learning app by leading educational technology experts! A group of Language education specialists and technology analysts have officially designated Migaku [https://migaku.com/] as the best language learning app [https://migaku.com/] following comprehensive evaluation of its innovative approach to language acquisition. Built for serious learners seeking genuine fluency, Migaku combines cutting-edge immersion technology, real-world content, and intelligent personalization to dramatically accelerate language mastery. Migaku's revolutionary approach centers on
Anti-CD152 Antibody Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Precision Biosciences, TG Therapeutics, RemeGen, Caribou Biosciences, Xencor
Anti-CD152 Antibody Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Anti-CD152 Antibody pipeline constitutes key companies continuously working towards developing Anti-CD152 Antibody treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Anti-CD152 Antibody Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/anti-cd152-antibody-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Anti-CD152 Antibody Market. The Anti-CD152 Antibody Pipeline report embraces in-depth
AL Amyloidosis Pipeline 2025: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | Sorrento Therapeutics, Prothena Therapeutics, Spectrum Pharma, Takeda, Millennium Pharma
AL Amyloidosis Pipeline 2025: In-depth Clinical Trials Analysis and Emerging The …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, AL Amyloidosis pipeline constitutes 10+ key companies continuously working towards developing 10+ AL Amyloidosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "AL Amyloidosis Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/al-amyloidosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the AL Amyloidosis Market. The AL Amyloidosis Pipeline report

All 5 Releases


More Releases for Gold

Gold Concentrate Market Is Going to Boom | Major Giants - Barrick Gold, Gold Fie …
HTF MI just released the Global Gold Concentrate Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Major Manufacturers are covered: Barrick Gold (CAN), Newmont (US), AngloGold Ashanti
Gold Mining Market - Key Players & Qualitative Insights 2025 | Gold Corp, Barric …
Global Gold Mining Market: Overview A variety of techniques are typically used to obtain gold from gold ores in the ground. They are: placer mining, sluicing, gold panning, dredging, hard-rock mining, rocker box, and by product mining. Gold mining has been carried out since ages and is a flourishing market even today. The high demand for gold as a potential mode of investment and the use of gold for making jewelry
Global Gold Mining Market to 2025: Newmont Mining, Gold Reserve, Royal Gold, Hom …
Researchmoz added Most up-to-date research on "Global Gold Mining Market Insights, Forecast to 2025" to its huge collection of research reports. This report researches the worldwide Gold Mining market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global Gold Mining breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth
Gold Metals Market Demands with Major Quality Things: Pure Gold, Mixed Color Gol …
Gold Metals Market By Product (Pure Gold, Mixed Color Gold, Color Gold and Other Products) and Application (Luxury Goods, Automotive, Electronics and Other Applications) - Global Industry Analysis And Forecast To 2025. Industry Outlook: The gold is an element having the symbol Au (from the Latin name: aurum) and the atomic number been 79, making it the element with higher atomic number that happen normally. In the most pure form, it is
Gold Mining Market Highlights On Product Demand 2025 | Gold Corp, Barrick Gold
Global Gold Mining Market: Overview A variety of techniques are typically used to obtain gold from gold ores in the ground. They are: placer mining, sluicing, gold panning, dredging, hard-rock mining, rocker box, and by product mining. Gold mining has been carried out since ages and is a flourishing market even today. The high demand for gold as a potential mode of investment and the use of gold for making jewelry
Gold Mining Market - Heightened demand 2025 | Gold Corp, Barrick Gold
Global Gold Mining Market: Overview A variety of techniques are typically used to obtain gold from gold ores in the ground. They are: placer mining, sluicing, gold panning, dredging, hard-rock mining, rocker box, and by product mining. Gold mining has been carried out since ages and is a flourishing market even today. The high demand for gold as a potential mode of investment and the use of gold for making jewelry